These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1891973)

  • 1. Protective effects of calmodulin antagonists (trifluoperazine and W-7) on hypothermic ischemic rat hearts.
    Sugawara E; Nakayama Y; Senoo Y; Teramoto S
    Acta Med Okayama; 1991 Jun; 45(3):129-34. PubMed ID: 1891973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin antagonist reduces release of malondialdehyde from isolated ischemic/reperfused rat heart.
    Beresewicz A; Wasilewska A; Herbaczyńska-Cedro K
    Acta Physiol Pol; 1988; 39(5-6):442-9. PubMed ID: 3257057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts.
    Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Grover GJ
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):251-60. PubMed ID: 1381016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonists of calmodulin delay injury development in the severely ischemic perfused working rat heart.
    Beresewicz A
    Acta Physiol Pol; 1988; 39(4):225-43. PubMed ID: 3075408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hypothermic reperfusion and postischemic recovery in isolated rat heart.
    Kempsford RD; Murashita T; Hearse DJ
    Am J Physiol; 1990 Sep; 259(3 Pt 2):H879-88. PubMed ID: 2396694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization.
    Otani H; Engelman RM; Rousou JA; Breyer RH; Clement R; Prasad R; Klar J; Das DK
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):267-74. PubMed ID: 2915562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ischemic and membrane stabilizing activity of calmodulin inhibitors.
    Beresewicz A
    Basic Res Cardiol; 1989; 84(6):631-45. PubMed ID: 2619700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin antagonists stimulate renin release from isolated rat glomeruli.
    Kawamura M; Inagami T
    Endocrinology; 1983 May; 112(5):1857-9. PubMed ID: 6187563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
    Barron E; Marshall RJ; Martorana M; Winslow E
    Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of calmodulin in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
    Marone G; Poto S; Columbo M; Giugliano R; Genovese A; Condorelli M
    J Pharmacol Exp Ther; 1984 Dec; 231(3):678-84. PubMed ID: 6502522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diltiazem on functional recovery and myocardial metabolism during hypothermic global ischemia and normothermic reperfusion.
    Kohda Y; Tominaga R; Ueno Y; Tokunaga K
    Jpn J Surg; 1983 May; 13(3):246-53. PubMed ID: 6632397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of ischemic and reperfusion arrhythmias using the calmodulin blocker trifluoperazine].
    Meerson FZ; Malyshev IIu; Larionov NP; Karpov RS
    Kardiologiia; 1988 May; 28(5):91-5. PubMed ID: 3411868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of in vitro virulence by Entamoeba histolytica: effect of calmodulin inhibitors.
    Arias-Negrete S; Muñoz Mde L; Murillo-Jasso F
    APMIS; 1999 Sep; 107(9):875-81. PubMed ID: 10519325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calmodulin inhibitors on thyroid hormone secretion.
    Nakai A; Nagasaka A; Hidaka H; Tanaka T; Ohyama T; Iwase K; Ohtani S; Shinoda S; Aono T; Masunaga R
    Endocrinology; 1986 Nov; 119(5):2279-83. PubMed ID: 3021438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by calmodulin antagonists of glioblast DNA synthesis and morphological changes induced by glia maturation factor.
    Okumura K; Kato T; Ito J; Tanaka R
    Brain Res; 1982 Apr; 255(4):662-7. PubMed ID: 7074367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-dependence of the effect of trifluoperazine as a protective agent during cardioplegia in the isolated working rat heart.
    Beresewicz A; Mistarz K; Demkow M
    Biomed Biochim Acta; 1990; 49(10):1039-48. PubMed ID: 2080904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin antagonists stimulate renin secretion and inhibit renin synthesis in vitro.
    Della Bruna R; Pinet F; Corvol P; Kurtz A
    Am J Physiol; 1992 Mar; 262(3 Pt 2):F397-402. PubMed ID: 1558157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of nifedipine in the isolated cat heart.
    Okamatsu S; Lefer AM
    J Surg Res; 1983 Jul; 35(1):35-40. PubMed ID: 6865391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
    Stout MA; Silver PJ
    J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.